EGFR Positive Non-small Cell Lung Cancer

Showing NaN - NaN of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

EGFR Positive NSCLC Trial in China (APG-1252, Osimertinib Mesylate Tablets)

Recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Oct 27, 2021

EGFR Positive NSCLC, Adenocarcinoma Trial in China (Sequential Icotinib Plus Chemotherapy, Icotinib)

Unknown status
  • EGFR Positive Non-small Cell Lung Cancer
  • Adenocarcinoma
  • Sequential Icotinib Plus Chemotherapy
  • Icotinib
  • Lanzhou, Gansu, China
  • +30 more
Apr 27, 2015